In order to comply with BIFR order dated 20th November, 2013 as well as SEBI order dated 28th March, 2014 to increase the public shareholding from 15.21% to 25% by 19th August, 2014. One of the promoters, M/s. Pharmaceutical Business Group (India) Ltd has offered for sale of 14,23,000 equity shares (approximately 9.79%) of the face value of Rs.5 each, by way of an offer for sale through the Stock Exchange mechanism and the sale shall take place on August […]

BIFR referred Gujarat Themis Biosyn Ltd., has significantly surpassed the profitability projections as per scheme of Rehabilitation. Net Profit for the year ended 31st March, 2014 was Rs. 452.60 lakhs as against net profit of Rs. 106.98 lakhs for the year ended 31st March, 2013. The negative Net worth of the Company has come down to Rs.534 lakhs as on 31st March 2014 as against Rs. 987 lakhs on 31st March 2013. EPS for the current year stood at Rs. […]

In line with order passed by BIFR on 20th November, 2013 and 2nd January 2014, SEBI passed an order dated 28th March, 2014 allowing the Company to extend the time to comply with minimum public shareholding on or before 19th August, 2014. Also the Company allowed to increase in equity shares from 14,71,250 to 18,96,500 of Rs. 5/- each fully paid up, through public offer or private offer or through any other mode as well as at price as permitted […]

Gujarat Themis Biosyn Ltd. has recorded turnover of Rs. 2294.10 Lakhs for the current nine months ended 31st December, 2013, as compared to Rs.2104.08 Lakhs during the corresponding period ended 31st December, 2012. The Company recorded Net Profit of Rs.317.64 Lakhs for the current nine months ended 31st December, 2013 as compared to Rs.111.56 Lakhs during the corresponding period ended 31st December, 2012. The profit generation recorded exceeds the BIFR approved Scheme for the period under reference.

Gujarat Themis Biosyn Limited (GTBL) for which Rehabilitation Scheme was sanctioned by Board for Industrial Reconstruction (BIFR) on 12.01.2012. The Company under the umbrella of Themis Medicare’s management has started yielding positive results. The Company has a long term contract with a Pharma major to manufacture Active Pharmaceutical Ingredient (API). GTBL started positive profits from September 2012 quarter and thereafter the profits have been consistently on rise. Whereas in the quarter ended June 2013 profit of Rs. 84.78 lakhs was […]